Veru Inc (VERU) Stock Price, News, Quotes-Moomoo

$Veru Inc (VERU.US)$ Veru Presents Phase 2 and 3 Enobosarm Data At ADA Scientific Sessions: Well-Tolerated With Comparable Adverse Event Profile To Placebo; Effective In Reducing Fat And Preserving Lean Mass In Older Adults And Cancer Patients

seb240sx

May 29 21:20

$Veru Inc (VERU.US)$ what happen ? bad news ?

seb240sx

May 9 14:49

insider buyer 🤟

$Veru Inc (VERU.US)$ 376 000 share acquire by STEINER MITCHELL SHUSTER
and 102 000 share to FISCH HARRY

Sean Parker

May 8 06:07

news

$Veru Inc (VERU.US)$
Veru Reports Fiscal 2024 Second Quarter Financial Results and
Progress of its Enobosarm High Quality Weight Loss Clinical Program
—Phase 2b clinical study of enobosarm in combination with semaglutide (Wegovy®*) for highquality weight loss is actively enrolling—
—Company assembles esteemed high quality weight loss Scientific Advisory Board – five MDswith significant relevant medical, clinical and scientific expertise—
—Company to present this month at upcoming American Ass...

Analyst Rating

No Data

Price Target

No Data

Overall

VERU Veru Inc

Trade Overview

Capital Trend

News

Comments

Analysis

Analyst Rating

Price Target